Integrins: therapeutic targets in airway hyperresponsiveness and remodelling?

Trends Pharmacol Sci. 2014 Nov;35(11):567-74. doi: 10.1016/j.tips.2014.09.006. Epub 2014 Oct 16.

Abstract

Integrins are a group of transmembrane heterodimeric proteins that mediate cell-cell and cell-extracellular matrix (ECM) interactions. Integrins have been under intense investigation for their role in inflammation in asthma. Clinical trials investigating integrin antagonists, however, have shown that these compounds are relatively ineffective. Airway remodelling is another pathological feature of asthma that is thought to make an important contribution to airway hyperresponsiveness (AHR) and lung function decline. Recent studies have identified integrins as important players in this process, with a particular role for β1 and αv integrins. Here we review the role of these integrins in airway remodelling and hyperresponsiveness in obstructive airway disease and their potential as pharmacological targets for future treatment.

Keywords: airway fibroblast; airway hyperresponsiveness; airway remodelling; airway smooth muscle; integrin.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Airway Remodeling / drug effects
  • Animals
  • Anti-Asthmatic Agents / pharmacology*
  • Asthma / drug therapy
  • Asthma / metabolism
  • Asthma / pathology
  • Bronchial Hyperreactivity / drug therapy*
  • Bronchial Hyperreactivity / metabolism*
  • Bronchial Hyperreactivity / pathology
  • Bronchodilator Agents / pharmacology*
  • Humans
  • Integrins / metabolism*
  • Molecular Targeted Therapy
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Pulmonary Disease, Chronic Obstructive / metabolism
  • Pulmonary Disease, Chronic Obstructive / pathology

Substances

  • Anti-Asthmatic Agents
  • Bronchodilator Agents
  • Integrins